| Literature DB >> 34515601 |
Kaela E Shaw1, Alexa M Bersenas1, Shane W Bateman1, Shauna L Blois1, R Darren Wood2.
Abstract
Our goal was to validate a human hyaluronic acid (HA) ELISA (Hyaluronic acid plus ELISA; TECOmedical Group) for use in feline plasma. Plasma from 5 healthy cats and 5 critically ill cats was used for validation of the assay. Validation methods performed included intra- and inter-assay variability, spike-and-recovery, and dilutional linearity. All measurements were performed in duplicate. The precision study revealed good intra-assay CV of 7.4-8.9%; inter-assay CV was 3.4-4.2%. Extraction efficiency via spiking tests yielded mean recovery of 89.6%. The assay met criteria for acceptable linearity using 3 serial dilutions. Our results demonstrate that this commercial HA ELISA had acceptable analytical performance using feline plasma and could be a useful tool in the veterinary clinical research setting.Entities:
Keywords: ELISA; endothelial glycocalyx; feline; hyaluronic acid; validation
Mesh:
Substances:
Year: 2021 PMID: 34515601 PMCID: PMC8689016 DOI: 10.1177/10406387211044718
Source DB: PubMed Journal: J Vet Diagn Invest ISSN: 1040-6387 Impact factor: 1.279